As Seattle and outlying areas serve as the front lines of the coronavirus outbreak in the United States, with at least 10 deaths related to COVID-19 reported in the state of Washington, Fred Hutchinson Cancer Research Center implemented a mandatory remote work policy.

Japanese drug manufacturer Takeda Pharmaceutical indicated that the company is attempting to develop a drug based on the blood of patients who recovered from COVID-19.

The World Health Organization (WHO) warned of a global shortage and price gouging for protective equipment to fight the fast-spreading coronavirus and asked companies and governments to increase production by 40 percent as the death toll from the respiratory illness mounted.

Waltham, Massachusetts-based Thermo Fisher Scientific is acquiring Qiagen N.V., based in Venlo, The Netherlands. Thermo Fisher is offering 39 euros per share in cash for a transaction total of about $11.5 billion, and is also taking on $1.4 billion of net debt.

The Trump administration secured commitments from top pharmaceutical companies to work together to develop a vaccine and treatments to fight the coronavirus.

On the same day the White House tapped Vice President Mike Pence to lead the government response to the coronavirus, the Biotechnology Innovation Organization (BIO) tapped George Scangos to head up its own response to the outbreak, which causes the COVID-19 disease.

Gilead Sciences Inc. is buying Forty Seven Inc. for $95.50 per share, or a deal value of $4.9 billion. The deal was unanimously approved by both companies’ boards.

Health officials in Washington state said a nursing home resident died after contracting coronavirus, while New York’s governor confirmed his state’s first positive case, as the virus moved out of its West Coast foothold.

The U.S. Department of Health and Human Services is investigating a manufacturing defect in some initial coronavirus test kits that prompted some states to seek emergency approval to use their own test kits.

The novel coronavirus that causes the disease COVID-19 continues to spread and has been diagnosed in more than 50 countries